6 results  1 of 1 

1 Evaluation of P57, P53 and Ki67 Expression in Meningiomas
İlknur Küçükosmanoğlu, Meryem İlkay Eren Karanis, Yaşar Ünlü, İlker Çöven
J Korean Neurosurg Soc.2022;65(4):499-506.   Published online 2022 April 14     DOI: http://dx.doi.org/10.3340/jkns.2021.0197
      
2 Clinical Implementation of Precision Medicine in Gastric Cancer
Jaewook Jeon, Jae-Ho Cheong
J Gastric Cancer.2019;19(3):235-253.   Published online 2019 August 12     DOI: http://dx.doi.org/10.5230/jgc.2019.19.e25
      
3 Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data
Xiaokang Yu, Jinsheng Liang, Jiarui Xu, Xingsong Li, Shan Xing, Huilan Li, Wanli Liu, Dongdong Liu, Jianhua Xu, Lizhen Huang, Hongli Du
J Breast Cancer.2018;21(4):363-370.   Published online 2018 December 10     DOI: http://dx.doi.org/10.4048/jbc.2018.21.e56
      
4 Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong-Man Kim, Shin-Wha Lee, Young-Jae Lee, Ha-Young Lee, Jong-Eun Lee, Eun-Kyung Choi
J Gynecol Oncol.2019;30(3):e32.  Published online 2018 November 23     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e32
      
5 BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
Yong Hwa Eom, Hyung Suk Kim, Ahwon Lee, Byung Joo Song, Byung Joo Chae
J Breast Cancer.2016;19(3):252-260.   Published online 2016 September 23     DOI: http://dx.doi.org/10.4048/jbc.2016.19.3.252
      
6 The role of microRNAs in bladder cancer
Hideki Enokida, Hirofumi Yoshino, Ryosuke Matsushita, Masayuki Nakagawa
Investig Clin Urol.2016;57(Suppl 1):S60-S76.   Published online 2016 June 7     DOI: http://dx.doi.org/10.4111/icu.2016.57.S1.S60
      

 1 of 1